Cancer Incidence in 677 Mitoxantrone-Treated People with Multiple Sclerosis: A Retrospective German Single Center Cohort Study

被引：0
|
作者：
Buttmann, Mathias [1 ]
Seuffert, Linda [1 ]
Maeder, Uwe [2 ]
Stoll, Guido [1 ]
Toyka, Klaus [1 ]
机构：
[1] Univ Wurzburg, Dept Neurol, Wurzburg, Germany
[2] Univ Wurzburg, Canc Registry, Wurzburg, Germany
来源：
NEUROLOGY | 2013年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P01175
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational study
    Le Page, Emmanuelle
    Deburghgraeve, Veronique
    Lester, Marie-Antoinette
    Cardiet, Isabelle
    Leray, Emmanuelle
    Edan, Gilles
    JOURNAL OF NEUROLOGY, 2015, 262 (04) : 1024 - 1034
  • [22] Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational study
    Emmanuelle Le Page
    Véronique Deburghgraeve
    Marie-Antoinette Lester
    Isabelle Cardiet
    Emmanuelle Leray
    Gilles Edan
    Journal of Neurology, 2015, 262 : 1024 - 1034
  • [23] Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study
    Seery, N.
    Sharmin, S.
    Li, V.
    Nguyen, A.
    Meaton, C.
    Atvars, R.
    Taylor, N.
    Tunnell, K.
    Carey, J.
    Marriott, M. P.
    Buzzard, K. A.
    Roos, I.
    Dwyer, C.
    Baker, J.
    Taylor, L.
    Spriggs, K.
    Kilpatrick, T. J.
    Kalincik, T.
    Monif, M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 : 32 - 33
  • [24] Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study
    Seery, Nabil
    Sharmin, Sifat
    Li, Vivien
    Nguyen, Ai-Lan
    Meaton, Claire
    Atvars, Roberts
    Taylor, Nicola
    Tunnell, Kelsey
    Carey, John
    Marriott, Mark P.
    Buzzard, Katherine A.
    Roos, Izanne
    Dwyer, Chris
    Baker, Josephine
    Taylor, Lisa
    Spriggs, Kymble
    Kilpatrick, Trevor J.
    Kalincik, Tomas
    Monif, Mastura
    CNS DRUGS, 2021, 35 (08) : 907 - 918
  • [25] Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study
    Seery, N.
    Sharmin, S.
    Li, V.
    Nguyen, A.
    Meaton, C.
    Atvars, R.
    Taylor, N.
    Tunnell, K.
    Carey, J.
    Marriott, M. P.
    Buzzard, K. A.
    Roos, I.
    Dwyer, C.
    Baker, J.
    Taylor, L.
    Spriggs, K.
    Kilpatrick, T. J.
    Kalincik, T.
    Monif, M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (4_SUPPL) : 32 - 33
  • [26] Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study
    Nabil Seery
    Sifat Sharmin
    Vivien Li
    Ai-Lan Nguyen
    Claire Meaton
    Roberts Atvars
    Nicola Taylor
    Kelsey Tunnell
    John Carey
    Mark P. Marriott
    Katherine A. Buzzard
    Izanne Roos
    Chris Dwyer
    Josephine Baker
    Lisa Taylor
    Kymble Spriggs
    Trevor J. Kilpatrick
    Tomas Kalincik
    Mastura Monif
    CNS Drugs, 2021, 35 : 907 - 918
  • [27] Alemtuzumab as rescue therapy in a cohort of 15 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational study
    Le Page, E.
    Deburghgraeve, V.
    Cardiet, I.
    Lester, M. A.
    Edan, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 191 - 191
  • [28] Incidence and risk of hypertension in patients newly treated for multiple myeloma: a retrospective cohort study
    Ajai Chari
    Khalid Mezzi
    Shao Zhu
    Winifred Werther
    Diana Felici
    Alexander R. Lyon
    BMC Cancer, 16
  • [29] Incidence and risk of hypertension in patients newly treated for multiple myeloma: a retrospective cohort study
    Chari, Ajai
    Mezzi, Khalid
    Zhu, Shao
    Werther, Winifred
    Felici, Diana
    Lyon, Alexander R.
    BMC CANCER, 2016, 16
  • [30] Incidence and Characteristics of Multiple Primary Cancers: A 20-Year Retrospective Study of a Single Cancer Center in Korea
    Kwon, Jin-Hee
    Kim, Heyjin
    Lee, Jin Kyung
    Hong, Young Jun
    Kang, Hye Jin
    Jang, Yoon Jung
    CANCERS, 2024, 16 (13)
12345